Adjuvant chemotherapy for patients with primary hepatocellular carcinoma: A meta‐analysis
- 19 September 2014
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 136 (6) , E751-9
Abstract
Numerous studies have investigated the effects of adjuvant chemotherapy for primary hepatocellular carcinoma (HCC) patients. We conducted this analysis to evaluate the efficacy of adjuvant chemotherapy in HCC patients after hepatectomy. PubMed/MEDLINE, EMBASE, Cochrane, and other databases were searched for eligible studies. The major endpoints were overall survival (OS) and disease‐free survival (DFS). The pooled odds ratio (OR) was calculated using a random‐effects model to summarize the results. In the meta‐analysis of 13 randomized control trials (RCTs) and 35 observational studies with 4747 patients, hepatectomy plus adjuvant chemotherapy showed superiority over hepatectomy alone in 1‐year DFS (OR = 1.86, 1.38–2.51, p < 0.001), 3‐year DFS (OR = 2.37, 1.73–3.24, p < 0.001) and 5‐year DFS (OR = 1.99, 1.55–2.55, p < 0.001), as well as 1‐year OS (OR = 2.16, 95% confidence interval 1.75–2.68, p < 0.001), 3‐year OS (OR = 1.77, 1.48–2.13, p < 0.001) and 5‐year OS (OR = 1.92, 1.44–2.56, p < 0.001). Subgroup and sensitivity analysis revealed that only adjuvant TACE had significant survival benefits. The meta‐analysis of studies involving patients with portal vein tumor thrombus (PVTT), but not other factors related to recurrence risk, revealed favorable outcomes of the Treatment arm over the Control arm. The present study shows that adjuvant chemotherapy can improve outcomes for HCC patients. The benefits of adjuvant TACE have been confirmed whereas the effects of other adjuvant chemotherapy modalities remain uncertain. Adjuvant chemotherapy is likely to be more applicable to certain patient populations for instance those with PVTT, but further research in identifying these patient factors is of importance for tailoring adjuvant therapies to individual patients in the future.Keywords
Funding Information
- Key Clinical Project from the Ministry of Health (2010159)
- National High Technology Research and Development Program of China (863 Program) (2012AA021008)
- National Natural Science Foundation of China (30972951, 81102244, 81102245, and 81170448)
- Project by Division of Medical Service Management of the Ministry of Health (2010)
- Special Fund for Science Research by Ministry of Health (201002004 and 201302009)
- The Major Sci-tech Special Program of Science and Technology Planning Project of Guangzhou City (2012Y2-00016)
- The Research Fund for the Doctoral Program of Higher Education of China by the Ministry of Education (20100171110063, 20110171120077 and 20120171110073)
- The Science and Technology Planning Key Clinical Project of Guangdong Province (2011A030400005)
- the Science and Technology Project of Guangdong Province (2010B031600222)
- The State Key Clinical Specialty Construction Project
This publication has 16 references indexed in Scilit:
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- Sorafenib in liver cancerExpert Opinion on Pharmacotherapy, 2012
- Adjuvant Chemolipiodolization Reduces Early Recurrence Derived from Intrahepatic Metastasis of Hepatocellular Carcinoma After HepatectomyAnnals of Surgical Oncology, 2011
- Differentiation-Inducing Activity of Hydroxycamptothecin on Cancer Stem-Like Cells Derived from Hepatocellular CarcinomaDigestive Diseases and Sciences, 2011
- Postoperative adjuvant transarterial chemoembolization for participants with hepatocellular carcinoma: A meta‐analysisHepatology Research, 2010
- A comparative study of high-dose hepatic arterial infusion chemotherapy and transarterial chemoembolization using doxorubicin for intractable, advanced hepatocellular carcinomaThe Korean Journal of Hepatology, 2010
- Transarterial chemotherapy alone versus transarterial chemoembolization for hepatocellular carcinoma: A randomized phase III trialJournal of Hepatology, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Results of Surgical and Nonsurgical Treatment for Small–Sized Hepatocellular Carcinomas: A Retrospective and Nationwide Survey in JapanHepatology, 2000
- Intrahepatic metastases in hepatocellular carcinoma: the role of the portal vein as an efferent vesselClinical & Experimental Metastasis, 1996